Drug Database
Back to search

Denmark· DK-28104017706

Piperacillin/Tazobactam "Fresenius Kabi"

A piperacillin und beta-lactamase-inhibitor product containing piperacillinnatrium, tazobactamnatrium, registered in Denmark by Fresenius Kabi AB. The same ATC class is registered in 12 of our 19 countries.

ATC J01CR05

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedPiperacillin/Tazobactam "Fresenius Ka…ATCJ01CR05REGISTER NO.DK-28104017706PACKS LISTED1CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about piperacillinnatrium, tazobactamnatriumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Piperacillin und beta-lactamase-inhibitor is registered in 12 of 19 countries.

Countries holding a registration under ATC J01CR05 (piperacillin und beta-lactamase-inhibitor), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 8 of them publish a price we can compare per daily dose
Search piperacillin und beta-lactamase-inhibitor products by name

Piperacillin und beta-lactamase-inhibitor · ATC J01CR05

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of piperacillin und beta-lactamase-inhibitor costs, country by country.

Normalised to the WHO defined daily dose (14 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Piperacillin und beta-lactamase-inhibitor · price per daily dose (14 g)

USD · FX 28 Sept 2026

  • CH Switzerland$158.68
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
PIPERACILLINNATRIUM, Tazobactamnatrium
Manufacturer
Fresenius Kabi AB
Country
Denmark (DK)
ATC code
J01CR05
ATC class
Piperacillin und Beta-Lactamase-Inhibitor
Defined daily dose
14 g, P
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28104017706

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

111 interactions on record for piperacillin und beta-lactamase-inhibitor.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check piperacillin und beta-lactamase-inhibitor against other medicinesHow interaction checks work

Piperacillin und beta-lactamase-inhibitor · interactions on record

111 records

  • 5 severe
  • 22 moderate
  • 4 minor
  • 80 info

Most severe, free to view

  • VancomycinA07AA09severe
  • VancomycinJ01XA01severe
  • MethotrexateL01BA01severe
  • MethotrexateL04AX03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J01CR05

Piperacillin und beta-lactamase-inhibitor, as other registers publish it.

All piperacillin und beta-lactamase-inhibitor products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aec9bbc9-e26c-419d-887a-df5e0f9e92f9
GET /v1/drugs/aec9bbc9-e26c-419d-887a-df5e0f9e92f9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "pulver til infusionsvæske, opløsning",
  "source": "dkma",
  "strength": "2+0,25 g",
  "auth_role": "CMS",
  "dk_drugid": "28104017706",
  "substance": "PIPERACILLINNATRIUM, Tazobactamnatrium",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": false,
  "registration_date_serial": "39723"
}
API referenceMCP serverPlans

See everything about piperacillin und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console